Antitumor Activity and Treatment-Related Toxicity Associated With Nivolumab Plus Ipilimumab in Advanced Malignancies: A Systematic Review and Meta-Analysis

Combining immune checkpoint inhibitors has shown its efficacy compared to monotherapy in advanced malignancies. We conducted this meta-analysis to provide latest evidence on the objective response rate (ORR) and incidence of treatment-related high-grade adverse events (AEs) during nivolumab and ipil...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hang, Tan, Ping, Ai, Jianzhong, Zhang, Shiyu, Zheng, Xiaonan, Liao, Xinyang, Yang, Lu, Wei, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844121/
https://www.ncbi.nlm.nih.gov/pubmed/31749704
http://dx.doi.org/10.3389/fphar.2019.01300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844121/
https://www.ncbi.nlm.nih.gov/pubmed/31749704
http://dx.doi.org/10.3389/fphar.2019.01300

Ejemplares similares